Index 
 Previous 
 Next 
 Full text 
Procedure : 2017/0340(NLE)
Document stages in plenary
Document selected : A8-0133/2018

Texts tabled :

A8-0133/2018

Debates :

Votes :

PV 03/05/2018 - 7.3

Texts adopted :

P8_TA(2018)0193

Texts adopted
PDF 241kWORD 42k
Thursday, 3 May 2018 - Brussels Final edition
Subjecting the new psychoactive substance ADB-CHMINACA to control measures *
P8_TA(2018)0193A8-0133/2018

European Parliament legislative resolution of 3 May 2018 on the draft Council implementing decision on subjecting the new psychoactive substance N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) to control measures (05387/2018 – C8-0028/2018 – 2017/0340(NLE))

(Consultation)

The European Parliament,

–  having regard to the Council draft (05387/2018),

–  having regard to Article 39(1) of the Treaty on European Union, as amended by the Treaty of Amsterdam, and Article 9 of Protocol No 36 on transitional provisions, pursuant to which the Council consulted Parliament (C8‑0028/2018),

–  having regard to Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances(1), and in particular Article 8(3) thereof,

–  having regard to Rule 78c of its Rules of Procedure,

–  having regard to the report of the Committee on Civil Liberties, Justice and Home Affairs (A8-0133/2018),

1.  Approves the Council draft;

2.  Calls on the Council to notify Parliament if it intends to depart from the text approved by Parliament;

3.  Asks the Council to consult Parliament again if it intends to substantially amend the text approved by Parliament;

4.  Instructs its President to forward its position to the Council and the Commission.

(1) OJ L 127, 20.5.2005, p. 32.

Last updated: 7 November 2018Legal notice